These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3088094)

  • 1. Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayannis A; Ticehurst JR; Feinstone SM; Purcell RH
    J Hepatol; 1986; 2(3):410-8. PubMed ID: 3088094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus DNA in blood specimens of anti HBc IgM positive patients.
    Hukkanen V; Hakkarainen K; Leinikki P; Hyypiä T
    Scand J Infect Dis; 1989; 21(2):133-7. PubMed ID: 2727633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatitis B virus DNA in serum and relation with the IgM class anti-HBc titers in hepatitis B virus infection.
    van Ditzhuijsen TJ; Selten GC; van Loon AM; Wolters G; Matthyssen L; Yap SH
    J Med Virol; 1985 Jan; 15(1):49-56. PubMed ID: 3968544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
    Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
    Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the prevalence of serum HBV DNA and immunoserologic HBV markers in the subjects with or without hepatitis.
    Luo KX; Zhou R; Liang ZS; Jiang S
    Immunol Invest; 1992 Jun; 21(3):275-81. PubMed ID: 1587559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.
    Tassopoulos NC; Kuhns MC; Koutelou MG; McNamara AL; Todoulos A
    Dig Dis Sci; 1993 Dec; 38(12):2156-62. PubMed ID: 8261815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
    Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
    Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
    Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
    Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
    Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
    J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of relativity between HBV M and HBV DNA in the cases with hepatitis B.
    Meng Q; Liang R; Liu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):352-4. PubMed ID: 11471024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV.
    Carloni G; Delfini C; Colloca S; Alfani E; Taliani G; De Bac C
    Arch Virol; 1986; 87(1-2):97-105. PubMed ID: 3942507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.